SCHEMBL9423587

SCHEMBL9423587

O=CNCc1cc2ccccc2n(-c2ccccc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
TSHR P16473 1/20 0.47
ADH1B P00325 1/20 0.40
ADH1C P00326 1/20 0.40
ADH1A P07327 1/20 0.40
ADH7 P40394 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 3/20 0.36
CYP19A1 P11511 1/20 0.36
MEN1 O00255 1/20 0.36
CRHBP P24387 1/20 0.36
RECQL P46063 1/20 0.36
CRHR2 Q13324 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HAO1 Q9UJM8 1/20 0.36
NOTUM Q6P988 1/20 0.35
PLA2G10 O15496 3/20 0.34
MAPK8 P45983 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9423251 0.80 ALDH1A1 (0.49) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423405 0.78 SETDB1 (0.42) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9395502 0.78 ALDH1A1 (0.49) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423391 0.78 ALDH1A1 (0.49) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423493 0.75 ALDH1A1 (0.46) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423502 0.74 ALDH1A1 (0.45) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423485 0.73 ALDH1A1 (0.44) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423486 0.73 ALDH1A1 (0.44) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423620 0.72 CYP19A1 (0.47) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL9423298 0.71 KDM4E (0.41) ALDH1A1TSHRKDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5318971-A Also antihyperproliferative skin disease agents, e.g. psoriaisis; side effect reduction SCHERING CORPORATION (US) 1994-06-07 US claimed
US-5318971-A Also antihyperproliferative skin disease agents, e.g. psoriaisis; side effect reduction SCHERING CORPORATION (US) 1994-06-07 US disclosed
US-5064837-A Antiallergens SCHERING CORPORATION (US) 1991-11-12 US disclosed